Google DeepMind released AlphaGenome 2 on Wednesday, a model that predicts how DNA changes affect individual cell types. It learned from over 100 million single-cell profiles and spots nearly twice as many variants that change gene activity. Scientists can use it free for non-commercial research through an API, but it is not approved for diagnosis.